Guidelines – KDIGO
Access KDIGO Clinical Practice Guidelines on your smartphone and tablet. Recommendation statements at your fingertips.
A diretriz de 2009 do “Kidney Disease: Improving Global Outcomes (KDIGO)” para a prática clínica no manejo do distúrbio ósseo e mineral da doença renal crônica (CKD–MBD) tem a intenção de colaborar com o profissional de saúde envolvido no tratamento de adultos e crianças com CKD nos estágios 3–5 em
Acute Kidney Injury (AKI) – KDIGO
KDIGO is in the process of developing the Clinical Practice Guideline for Acute Kidney Injury (AKI) and Acute Kidney Disease (AKD).
• La publicación de las Guias KDIGO y el Informe de la Conferencia son el primer paso para cambiar la práctica clínica. • En países de todo el mundo, KDIGO enseña sobre sus Guías e informes de conferencias en conferencias de práctica clínica y en presentaciones en congresos de nefrología locales y regionales. KDIGO IMPLEMENTACION
KDIGO - Supportive management of AKI 3.3.4: We suggest administering 0.8–1.0 g/kg/d of protein in non catabolic AKI patients without need for dialysis (2D), 1.0–1.5 g/kg/d in patients with AKI on RRT (2D), and up to a maximum of 1.7 g/kg/d in …
& 2013 KDIGO VOL 3|ISSUE 3|NOVEMBER 2013 This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE) www.publicationethics.org. TABLES 269 Table 1. Secondary causes of dyslipidemias Table 2. Examples of situations in which measuring cholesterol level might or might not change the management
CKD Evaluation and Management – KDIGO
Key highlights of the KDIGO CKD Guideline include guidance updates on the measurements of estimated glomerular filtration rate and albuminuria, utilization of CKD risk prediction equations, and personalized treatment recommendations for kidney and cardiovascular risk reductions tailored to individual patient needs and preferences.
Glomerular Diseases (GD) – KDIGO
KDIGO is updating The 2021 Clinical Practice Guideline for the Management of Glomerular Diseases on an ongoing, chapter-by-chapter basis. The KDIGO 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV) is being revised based on feedback received during the public review period.
Les recommandations KDIGO 2009 de bonnes pratiques cliniques consacrées à la prise en charge des TMO-MRC ont pour but d’aider les praticiens qui soignent des adultes et des enfants atteints de MRC de stade 3 à 5, ou dialysés chroniques ou transplantés rénaux. Ces recommandations portent sur l’évaluation
Evaluation, Prevention, and Treatment of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) with those that remained unchanged from the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD.